*  Deferoxamine mesylate / deferoxamine mesylate FDA New drug application 076019 global drug patent coverage, generic alternatives...
DEFEROXAMINE MESYLATE. deferoxamine mesylate. INJECTABLE;INJECTION. 076019. ANDA. Hospira, Inc.. 0409-2336. 0409-2336-10. 4 ... DEFEROXAMINE MESYLATE. deferoxamine mesylate. INJECTABLE;INJECTION. 076019. ANDA. Hospira, Inc.. 0409-2336. 0409-2336-13. 10 ... Additional details are available on the DEFEROXAMINE MESYLATE profile page. The generic ingredient in DEFEROXAMINE MESYLATE is ... NDA 076019 describes DEFEROXAMINE MESYLATE, which is a drug marketed by Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Watson ...
  https://www.drugpatentwatch.com/p/NDA/076019
*  Clinical Trials in the Spotlight | National Institute of Neurological Disorders and Stroke
Intracerebral Hemorrhage Deferoxamine (iDEF) Trial. The Intracerebral Hemorrhage Deferoxamine (iDEF) trial will study the ... Intracerebral Hemorrhage Deferoxamine (iDEF) Trial. The Intracerebral Hemorrhage Deferoxamine (iDEF) trial will study the ... The focus of this multi-center, double-blind, placebo-controlled study is to evaluate deferoxamine... ... The focus of this multi-center, double-blind, placebo-controlled study is to evaluate deferoxamine... ...
  https://www.ninds.nih.gov/Disorders/Clinical-Trials/Highlighted-Clinical-Trials
*  Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation - Full Text View - ClinicalTrials.gov
Deferoxamine for ,=2 weeks prior to stem cells. Drug: deferoxamine Given intravenously or subcutaneously over 8-12 hours daily ... Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation. The safety and scientific validity of this study is ... Safety of Deferoxamine Therapy Determined by the Number of Participants With Grade 3 or Higher Toxicities. [ Time Frame: ... In this study we are examining the use of deferoxamine starting 2 weeks to 3 months prior to transplantation and continuing ...
  https://clinicaltrials.gov/ct2/show/NCT00658411?term=leukemia+AND+
*  Desferal - Blink Price $1,072.80 | Blink Health
Deferoxamine is an iron-binding agent that belongs to a class of drugs known as heavy metal antagonists. It works by helping ... Before using deferoxamine, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This ... Consult your doctor or pharmacist for more details before starting deferoxamine.. This medication may interfere with certain ... cardiac function tests in patients using deferoxamine and vitamin C) should be performed periodically to monitor your progress ...
  https://www.blinkhealth.com/desferal
*  Abstract 336: Cardiac Function Improvement in Infarcted Rats Treated with an Association of N-acetylcysteine and Deferoxamine |...
Our aim was to test the association of NAC and an iron chelator (deferoxamine - DFX) on cardiac remodeling in a rodent model of ... Abstract 336: Cardiac Function Improvement in Infarcted Rats Treated with an Association of N-acetylcysteine and Deferoxamine. ... Abstract 336: Cardiac Function Improvement in Infarcted Rats Treated with an Association of N-acetylcysteine and Deferoxamine ... Abstract 336: Cardiac Function Improvement in Infarcted Rats Treated with an Association of N-acetylcysteine and Deferoxamine ...
  http://circres.ahajournals.org/content/115/Suppl_1/A336
*  Deferoxamine - Medical Dictionary / Glossary | Medindia
Deferoxamine' - An iron-chelating agent that removes iron from tumors by inhibiting DNA synthesis and causing cancer cell death ... Medical Word - Deferoxamine. Ans : An iron-chelating agent that removes iron from tumors by inhibiting DNA synthesis and ... Deferoxamine - Glossary. Written & Compiled by Medindia Content Team. Medically Reviewed by The Medindia Medical Review Team on ...
  http://www.medindia.net/glossary/deferoxamine.htm
*  Deferoxamine Lyophilisate For Solution For Injection 2G Drug Medication Dosage Information
... Learn about reported side effects, ... DEFEROXAMINE (dee fer OX a meen) helps to remove excess iron from the body. This may be necessary in patients who have received ...
  https://www.cvs.com/drug/deferoxamine/lyophilisate-for-solution-for-injection/2g
*  Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial - Full Text View - ClinicalTrials.gov
Experimental: Deferoxamine Mesylate Deferoxamine Mesylate (32 mg/kg/day) given by an intravenous infusion for 3 consecutive ... Deferoxamine Mesylate in Intracerebral Hemorrhage Investigators. Safety and tolerability of deferoxamine mesylate in patients ... Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial. The safety and scientific validity of this study is the ... Drug: Deferoxamine Mesylate Placebo Comparator: Normal Saline Normal saline (0.9% sodium chloride) given by intravenous ...
  https://clinicaltrials.gov/ct2/show/NCT02175225
*  Mechanisms underlying the promotion of functional recovery by deferoxamine
Abstract Deferoxamine, a clinically safe drug used for treating iron overload, also repairs spinal cord injury although the ... Mechanisms underlying the promotion of functional recovery by deferoxamine after spinal cord injury in rats. Hao J1, Li B1, ... Deferoxamine, a clinically safe drug used for treating iron overload, also repairs spinal cord injury although the mechanism ... Mechanisms underlying the promotion of functional recovery by deferoxamine Neural Regen Res. 2017 Jun;12(6):959-968. Mechanisms ...
  http://sci.rutgers.edu/forum/showthread.php?260687-Mechanisms-underlying-the-promotion-of-functional-recovery-by-deferoxamine&s=d83c2dafc5927347f4fb3f26f692ecfe&p=1837726
*  Deferoxamine - What does Deferoxamine stand for? The Free Dictionary
Deferoxamine is listed in the World's largest and most authoritative dictionary database of abbreviations and acronyms ... Looking for online definition of Deferoxamine or what Deferoxamine stands for? ... Deferoxamine - What does Deferoxamine stand for? The Free Dictionary https://acronyms.thefreedictionary.com/Deferoxamine ... redirected from Deferoxamine). Also found in: Medical, Wikipedia. Acronym. Definition. DFO. Department of Fisheries and Oceans ...
  http://acronyms.thefreedictionary.com/Deferoxamine
*  Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients
No known allergy or contraindication to the administration of deferoxamine. - Ability to comply with all study-related ... 20 mg/kg/Day Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients With Iron Overload From Repeated Blood ... 20 mg/kg/Day Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients With Iron Overload From Repeated Blood ...
  http://www.knowcancer.com/cancer-trials/NCT00110617/
*  Deferoxamine - Wikipedia
Deferoxamine is a siderophore from the bacteria Streptomyces pilosus. Deferoxamine was approved for medical use in the United ... Deferoxamine is used to treat acute iron poisoning, especially in small children. This agent is also frequently used to treat ... Deferoxamine acts by binding free iron in the bloodstream and enhancing its elimination in the urine. By removing excess iron, ... Deferoxamine is being studied as a treatment for spinal cord injury and intracerebral hemorrhage. It is also used to induce ...
  https://en.wikipedia.org/wiki/Deferoxamine
*  Ascorbate and Deferoxamine Administration after Chlorine Exposure Decrease Mortality and Lung Injury in Mice
... and 0.3 mg of deferoxamine (deferoxamine mesylate; Hospira, Lakeforest, IL) starting at 1 hour after exposure and every 12 ... Ascorbate and deferoxamine treatment decreased BAL lipid peroxidation in Cl2-exposed mice. Mice were exposed to 600 ppm of Cl2 ... Ascorbate and Deferoxamine Treatment Ameliorates Alveolar-Capillary Barrier Damage. As shown in Figure 4, Cl2-exposed mice ... Thus, ascorbate and deferoxamine may need to be administered more frequently, by additional routes (i.e., intravenously), or ...
  http://pubmedcentralcanada.ca/pmcc/articles/PMC3175564/?lang=en-ca
*  Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to...
Deferoxamine. Deferasirox. Siderophores. Iron Chelating Agents. Chelating Agents. Sequestering Agents. Molecular Mechanisms of ... and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).. This study has been completed. ... of Repeated Doses of 5-30mg/kg/Day ICL670 Relative to Deferoxamine (DFO) in Sickle Cell Disease (SCD) Patients With ...
  https://clinicaltrials.gov/ct2/show/NCT01090323
*  Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias - Full...
Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias. This ... Beta-thalassemia patients unable to be treated with deferoxamine or patients with rare chronic anemias such as Myelodysplastic ... Beta-thalassemia patients with documented non-compliance to deferoxamine, defined as taking less than 50% of prescribed doses ... Beta-thalassemia patients unable to take deferoxamine because of documented side effects or contra-indication, or documented ...
  https://clinicaltrials.gov/ct2/show/NCT00061763?cond=%22Anemia%22&rank=9
*  Deferoxamine mesylate / deferoxamine mesylate NDA 076806 global drug patent coverage, generic alternatives and suppliers
Additional details are available on the DEFEROXAMINE MESYLATE profile page. The generic ingredient in DEFEROXAMINE MESYLATE is ... NDA 076806 describes DEFEROXAMINE MESYLATE, which is a drug marketed by Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Watson ... deferoxamine mesylate. There are seven drug master file entries for this compound. Four suppliers are listed for this compound ...
  https://www.drugpatentwatch.com/p/NDA/076806
*  Distortion-product otoacoustic emission: early detection in deferoxamine induced ototoxicity - UnissResearch
Deferoxamine therapy in lifelong transfusion-dependent anaemias, as beta-thalassemia major, is associated with an increased ... Deferoxamine, ototoxicity, pure-tone audiometry, distortion-product otoacoustic emissions. Subjects:. Area 06 - Scienze mediche ... early detection in deferoxamine induced ototoxicity.. Auris Nasus Larynx, Vol. 35 (2), p. 198-202. ISSN 0385-8146. Article. ...
  http://eprints.uniss.it/1976/
*  "Deferoxamine effects on Plasmodium falciparum gene expression" by Ann M. Moormann, Paul A. Hossler et al.
Moormann, Ann M.; Hossler, Paul A.; and Meshnick, Steven R., "Deferoxamine effects on Plasmodium falciparum gene expression" ( ... Animals; Antimalarials; Deferoxamine; Gene Expression; Iron; Iron Chelating Agents; Mitochondria; Plasmodium falciparum ...
  https://escholarship.umassmed.edu/qhs_pp/381/
*  Deferoxamine retinopathy: spectral domain-optical coherence tomography findings | BMC Ophthalmology | Full Text
Spectral domain optical coherence tomographyDeferoxamineRetinopathy. Background. Deferoxamine is an iron-chelating agent used ... Deferoxamine is a widely used chelating agent in treating transfusional hemochromatosis [1, 5]. Visual symptoms included ... Deferoxamine retinopathy primarily targets the RPE-Bruch membrane-photoreceptor complex, extending from the peri-fovea to the ... The pathophysiology of deferoxamine-related retinopathy has been investigated for several years. Rahi et al. first reported ...
  https://bmcophthalmol.biomedcentral.com/articles/10.1186/1471-2415-14-88
*  Combination of deferasirox and deferoxamine in clinical practice: an alternative scheme of chelation in thalassemia major...
Only recently data from combination of Deferasirox/Deferoxamine (DFX/DFO) have been reported showing that it can be safe and ... The use of Deferiprone/Deferoxamine (DFP/DFO) combined in different schemes has been reported since many years. ... Combination of deferasirox and deferoxamine in clinical practice: an alternative scheme of chelation in thalassemia major ...
  http://www.echosensclinicallibrary.com/combination-of-deferasirox-and-deferoxamine-in-clinical-practice-an-alternative-scheme-of-chelation-in-thalassemia-major-patients
*  A Randomized, Open Label, Phase II Study on Safety and Efficacy of Long Term Treatment of ICL670 Relative to Deferoxamine in...
... is as safe as deferoxamine in preventing accumulation of iron in the body while a ... A Randomized, Open Label, Phase II Study on Safety and Efficacy of Long Term Treatment of ICL670 Relative to Deferoxamine in ... A Randomized, Open Label, Phase II Study on Safety and Efficacy of Long Term Treatment of ICL670 Relative to Deferoxamine in ...
  http://adisinsight.springer.com/trials/700248885?error=cookies_not_supported&code=60259dcb-441f-4cfc-8a6c-5130cb470214